Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-24 10:14 am Purchase | 2025-11-21 | 13G | Spruce Biosciences, Inc. SPRB | Boone Peter David Mr | 68,184 6.400% | 68,184 (New Position) | Filing History |
| 2025-11-07 4:30 pm Unchanged | 2025-10-31 | 13G | Spruce Biosciences, Inc. SPRB | Ikarian Capital, LLC | 121,356 11.400% | 0 (Unchanged) | Filing History |
| 2025-10-16 5:10 pm Purchase | 2025-10-09 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 109,649 9.990% | 109,649 (New Position) | Filing History |
| 2025-10-15 3:11 pm Purchase | 2025-10-08 | 13G | Spruce Biosciences, Inc. SPRB | Squadron Master Fund LP | 70,000 6.600% | 70,000 (New Position) | Filing History |
| 2025-10-09 5:33 pm Purchase | 2025-10-07 | 13D | Spruce Biosciences, Inc. SPRB | HealthCap VIII, L.P. | 36,640 3.400% | 36,640 (New Position) | Filing History |
| 2025-10-08 11:04 am Purchase | 2025-10-06 | 13G | Spruce Biosciences, Inc. SPRB | Ikarian Capital, LLC | 121,356 21.600% | 121,356 (New Position) | Filing History |
| 2025-08-13 4:31 pm Sale | 2025-07-03 | 13G | Spruce Biosciences, Inc. SPRB | Rock Springs Capital Management LP | 0 0.000% | -2,609,125 (Position Closed) | Filing History |
| 2025-08-13 4:26 pm Sale | 2025-06-30 | 13G | Spruce Biosciences, Inc. SPRB | Radoff Bradley Louis | 0 0.000% | -3,975,000 (Position Closed) | Filing History |
| 2025-02-13 12:50 pm Unchanged | 2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-01-10 11:05 am Sale | 2025-01-07 | 13D | Spruce Biosciences, Inc. SPRB | RiverVest Venture Fund III, L.P. | 23,460 4.200% | -23,570 (-50.12%) | Filing History |
| 2024-11-14 5:45 pm Sale | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | 5AM Opportunities II L.P. | 23,640 4.100% | -31,520 (-57.14%) | Filing History |
| 2024-11-14 4:39 pm Sale | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | Armistice Capital, LLC | 28,923 4.990% | -810 (-2.72%) | Filing History |
| 2024-11-12 4:10 pm Purchase | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | Radoff Bradley Louis | 53,000 9.600% | 15,333 (+40.71%) | Filing History |
| 2024-10-23 2:26 pm Sale | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors, Inc. | 0 0.000% | -20,112 (Position Closed) | Filing History |
| 2024-04-25 6:52 pm Sale | 2024-03-31 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors, Inc. | 20,112 3.670% | -10,848 (-35.04%) | Filing History |
| 2024-03-28 9:15 pm Sale | 2024-03-26 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 22,080 3.900% | -14,667 (-39.91%) | Filing History |
| 2024-03-28 12:42 pm Purchase | 2024-03-22 | 13G | Spruce Biosciences, Inc. SPRB | Radoff Bradley Louis | 37,667 6.900% | 37,667 (New Position) | Filing History |
| 2024-03-25 9:48 pm Sale | 2024-03-21 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 36,747 6.400% | -25,534 (-41.00%) | Filing History |
| 2024-03-20 9:31 pm Sale | 2024-03-18 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 62,280 10.900% | -23,933 (-27.76%) | Filing History |
| 2024-03-18 9:16 pm Sale | 2024-03-14 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 86,214 15.100% | -25,498 (-22.82%) | Filing History |